| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/09/2007 | US20070184490 Neuronal nicotinic receptor ligands and their use |
| 08/09/2007 | US20070184465 Methods for regulating hematopoiesis using CpG-oligonucleotides |
| 08/09/2007 | US20070184461 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/09/2007 | US20070184429 conjugated fluorescent dyes with a steroid; 3-oxo-N-(2-{[6-(9-oxoacridin-10(9H)-yl)hexanoyl]amino}ethyl)androst-4-ene-17-carboxamide; drug screening a test agent which modulate aromatase activity |
| 08/09/2007 | US20070184151 Use of a polyamine-poor composition for the production of a medical human food |
| 08/09/2007 | US20070184134 Phospholipid complexes of standardized vegetable extract of Vitis vinifera and of standardized vegetable extract of Centella asiatica; may also include vitamin E, zinc, hydroxyacids, or glycyrrhetinic acid or its complex with phospholipids; does not contain fish cartilage extract |
| 08/09/2007 | US20070184133 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 08/09/2007 | US20070184132 Methods of treating canine osteosarcoma |
| 08/09/2007 | US20070184131 Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof |
| 08/09/2007 | US20070184130 Formulation and method of use for animal ear treatment and homeopathic animal ear treatment |
| 08/09/2007 | US20070184124 Administering a corticosteroid selected from hydrocortisone, triamcinolone, betamethasone dipropionate, or clobetasol with precipitated sulfur; improved tolerability to treatment |
| 08/09/2007 | US20070184122 Fibronectin-modified ecm tissue graft constructs and methods for preparation and use thereof |
| 08/09/2007 | US20070184116 Pharmaceutical formulation containing unmilled flutamide |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | US20070184113 Pharmaceutical composition and process |
| 08/09/2007 | US20070184112 Volume Efficient Controlled Release Dosage Form |
| 08/09/2007 | US20070184110 Dipyridamole extended-release formulations and process for preparing same |
| 08/09/2007 | US20070184109 Compositions comprising triptans and nsaids |
| 08/09/2007 | US20070184108 Stable pharmaceutical formulations of montelukast sodium |
| 08/09/2007 | US20070184107 Moisture resistant container systems for rapidly bioavailable dosage forms |
| 08/09/2007 | US20070184106 Blister packaging for acute pain regimens |
| 08/09/2007 | US20070184105 Comsposition for stablizing epigallocatechin gallate (egcg) in water phase and preparation method thereof |
| 08/09/2007 | US20070184104 Gastric retentive gabapentin dosage forms and methods for using same |
| 08/09/2007 | US20070184103 Process for producing fenofibrate tablets |
| 08/09/2007 | US20070184101 Stable pharmaceutical formulations of montelukast sodium |
| 08/09/2007 | US20070184100 Contains a solid ibuprofen free acid and a solid ibuprofen alkali salt, and is characterized in that at least 90% of the weight of the solid ibuprofen concentrate is ibuprofen free acid and ibuprofen alkali salt; immediate release analgesics |
| 08/09/2007 | US20070184098 Esters of flavonoids with w-substituted c6-c22 fatty acids |
| 08/09/2007 | US20070184097 Adhesive preparations |
| 08/09/2007 | US20070184096 Stable Therapeutic Formulations |
| 08/09/2007 | US20070184091 Animal feed composition |
| 08/09/2007 | US20070184090 PUFA supplements |
| 08/09/2007 | US20070184089 Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use |
| 08/09/2007 | US20070184087 Polysaccharide compositions for use in tissue augmentation |
| 08/09/2007 | US20070184084 Implantable elastomeric caprolactone depot compositions and uses thereof |
| 08/09/2007 | US20070184082 Biocompatible polymeric delivery systems for sustained release of quinazolinones |
| 08/09/2007 | US20070184075 39-desmethoxyrapamycin, compositions and methods of use thereof |
| 08/09/2007 | US20070184061 Indolylmaleimide derivatives |
| 08/09/2007 | US20070184060 Method of using abscisic acid to treat and prevent diseases and disorders |
| 08/09/2007 | US20070184059 Method of cancer screening; method of cancer treatment; and method of diabetes treatment |
| 08/09/2007 | US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders |
| 08/09/2007 | US20070184055 Treatment with anti-erbb2 antibodies |
| 08/09/2007 | US20070184047 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction |
| 08/09/2007 | US20070184040 Compositions for delivery of coenzyme Q10 |
| 08/09/2007 | US20070184024 RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease; (+/-)-8-Cyclohexyl-N-4-(morpholinosulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-(3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxamide |
| 08/09/2007 | US20070184020 Combination of radio waves with pharmacologically active substances |
| 08/09/2007 | US20070184019 Pharmaceutical composition comprising an active principal and sulphobetaine |
| 08/09/2007 | US20070184017 Anti-aging treatment using copper and zinc compositions |
| 08/09/2007 | US20070184016 Composition and method for pre-surgical skin disinfection |
| 08/09/2007 | US20070184014 Modulation of Pathogenicity |
| 08/09/2007 | US20070184013 Antiviral method |
| 08/09/2007 | US20070183996 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | US20070183982 Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant |
| 08/09/2007 | US20070183980 Thermoforming by extrusion without discoloration; controlled release |
| 08/09/2007 | US20070183973 Direct application of non-toxic crosslinking reagents to resist progressive spinal deformity |
| 08/09/2007 | US20070183972 Compounds and methods for the treatment of cancer |
| 08/09/2007 | US20070181124 Method and apparatus for dispensing inhalator medicament |
| 08/09/2007 | DE102006005180A1 Indazol-heteroaryl-derivate Indazole-heteroaryl derivatives |
| 08/09/2007 | DE102006005179A1 Aminoindazolderivate Aminoindazolderivate |
| 08/09/2007 | DE102005062144A1 Ingwerfraktion zur Inhibierung humaner CYP Enzyme Ginger Group for inhibiting human CYP enzymes |
| 08/09/2007 | DE102005033903B4 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them |
| 08/09/2007 | DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome |
| 08/09/2007 | CA2641900A1 A new salt |
| 08/09/2007 | CA2641899A1 Water-soluble cc-1065 analogs and their conjugates |
| 08/09/2007 | CA2641817A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparation |
| 08/09/2007 | CA2641816A1 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies |
| 08/09/2007 | CA2641815A1 Method of treatment for muscular dystrophy |
| 08/09/2007 | CA2641345A1 Indazole derivatives for treatment of alzheimer's disease |
| 08/09/2007 | CA2641331A1 Identification of compounds suitable for treating ad |
| 08/09/2007 | CA2641304A1 Potassium channel inhibitors |
| 08/09/2007 | CA2641303A1 Na/k-atpase ligand |
| 08/09/2007 | CA2641146A1 Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/09/2007 | CA2641110A1 Potassium channel inhibitors |
| 08/09/2007 | CA2640976A1 Potassium channel inhibitors |
| 08/09/2007 | CA2640974A1 Method of treating chronic kidney disease |
| 08/09/2007 | CA2640966A1 Amorphous and crystalline forms of aprepitant and processes for the preparation thereof |
| 08/09/2007 | CA2640763A1 Method of reversing, preventing, delaying or stabilizing soft tissue calcification |
| 08/09/2007 | CA2640678A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 08/09/2007 | CA2640627A1 Crystalline forms of a farnesyl dibenzodiazepinone |
| 08/09/2007 | CA2640615A1 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 08/09/2007 | CA2640608A1 Potassium channel inhibitors |
| 08/09/2007 | CA2640598A1 Liposome preparation |
| 08/09/2007 | CA2640594A1 Thieno-pyridine derivatives as mek inhibitors |
| 08/09/2007 | CA2640584A1 Cationic steroid antimicrobial compositions and methods of use |
| 08/09/2007 | CA2640454A1 Compounds and methods for modulating protein trafficking |
| 08/09/2007 | CA2640444A1 Sterilized nanoparticulate glucocorticosteroid formulations |
| 08/09/2007 | CA2640432A1 Regimens for treatment of conditions related to estrogen deficiency |
| 08/09/2007 | CA2640409A1 Composition for inhibiting adhesion |
| 08/09/2007 | CA2640366A1 Method for treatment of neuropathic pain |
| 08/09/2007 | CA2640277A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists |
| 08/09/2007 | CA2640274A1 Benzoisoindole derivatives for the treatment of pain |
| 08/09/2007 | CA2640151A1 Compositions and methods for treatment of ophthalmic diseases and disorders |
| 08/09/2007 | CA2640049A1 Pyridylphenyl compounds for inflammation and immune-related uses |
| 08/09/2007 | CA2638887A1 Methods of treating degenerative disorders with rac 1b inhibitor |
| 08/09/2007 | CA2638784A1 Viral polymerase inhibitors |
| 08/09/2007 | CA2637846A1 A topical composition comprising an antibacterial substance |
| 08/09/2007 | CA2637836A1 Ang2 and vegf inhibitor combinations |
| 08/09/2007 | CA2637811A1 Benzisoxazole oxazolidinones as antibacterial agents |
| 08/09/2007 | CA2637546A1 Secondary amines as renin inhibitors |